We’re thrilled to share that the MMS team was honored among a prestigious group of prize-winners for our poster presentation at the recent PSI 2024 conference in Amsterdam! Kudos to Japie Lowings and Charl Janse van Rensburg for their insightful poster on the pros and cons of using external data sources in clinical trials. Their detailed work sparked valuable discussions on this crucial topic. To view their poster please click here: https://hubs.li/Q02HM0_V0 At the conference, our #OneMMS team was represented by Lucy Sutton, VP of Account Management and Japie Lowings, Principal Biostatistician. Reflecting on the conference, our team gathered key insights on how evolving biostatistics practices will influence future trial designs and analyses. We’re excited to share how these insights will shape our approach and drive success in clinical trials. Read the blog to gain perspectives on how our MMS biostatistics experts are preparing for change and driving success in trial design and analysis: https://hubs.li/Q02HM13x0 #PSI2024 #Biostatistics #ClinicalTrials #Pharma #Innovation #ExternalData #Estimands #BayesianMethodologies #OneMMS
MMS
Pharmaceutical Manufacturing
Canton, MI 50,427 followers
The difference is in the data.
About us
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com
- Website
-
https://www.mmsholdings.com
External link for MMS
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Canton, MI
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Clinical Strategy & Execution, Regulatory Affairs and Submissions, Clinical Programming & Biostatistics, Data Management, Clinical Trial Disclosures, Medical Writing, GCP Auditing, clinical research organization, Use of Real World Evidence, Pharmacovigilance & Drug Safety, Quality Control, Quality Assurance, and Data Science
Locations
Employees at MMS
Updates
-
Today is World Brain Day! Together, let’s take a moment to recognize the importance of mental health and neurological well-being. At MMS, we are committed to advancing research and innovation in neuroscience to improve lives globally. Thank you to our Sponsors who trust us to do this important work; we are grateful for you! Learn about the therapeutic areas that MMS specializes in here: https://hubs.li/Q02HpYdT0 #WorldBrainDay #Neuroscience #MentalHealth #BrainHealth #ClinicalResearch
-
MMS reposted this
Exciting to see details on the Rare Disease Innovation Hub by the FDA. At MMS, we have a long history of supporting Rare Disease data and applications including a probono effort for Ultra-rare diseases that our teams take great pride in. While every data point is important in clinical research, with rare diseases, this is even more crucial and with our Regulatory strategic experience and nimble full-service biometrics, MMS is your go to CRO for rare disease strategy and execution. #DataCRO #Rarediseases #OneMMS
-
MMS welcomes Ben Dudley as Chief Commercial Officer! Ben has over 25 years of experience in the life sciences industry, with a remarkable track record in drug development, sales and customer relationship management, operational leadership, and process optimization. Most recently, Ben served in operational and commercial leadership roles at Parexel, Covance, and AstraZeneca. His expertise in setting visionary strategies aligned with corporate imperatives, commitment to focused growth, and passion for customer relationships make him an invaluable addition to our leadership team. For details on Ben’s role within the MMS executive leadership, please view: https://hubs.li/Q02GVLZn0 #ClinicalResearchOrganization #Pharma #LifeSciences #DataCRO #OneMMS
-
In just 1 month, MMS will host the much-anticipated PHUSE SDE in South Africa! The SDE is co-chaired by Pieter Cloete, Senior Manager of Statistical Programming at MMS, and will focus on “The Efficiency Journey: Digital Transformation, Automation and Open Source.” This event will provide a valuable opportunity for biometrics experts and professionals to share their experiences and network with peers in the field. See all of the event details and registration link here: https://hubs.li/Q02Gx-W40 #PHUSE #Biometrics #PHUSESDE2024 #SouthAfrica
-
Clinical trials are becoming more complex, with sites spread further across multiple regions, placing a higher burden on Sponsors for pharmacovigilance regulatory compliance. If you are an early-stage drug development Sponsor or work with one, please attend today's webinar or request a copy of the recording to explore what constitutes a compliant pharmacovigilance program, learn of considerations as the new therapy progresses through key milestones, and understand the proper requirements to make informed decisions. It starts at 11AM EST! Last minute registration is still available here: https://hubs.li/Q02G9frG0 #OneMMS #DrugDevelopment #PV #Pharmacovigilance #DrugSafety #Pharmaceuticals
-
MMS is happy to share that our article "Unlocking the power of emotional intelligence in medical writers" has been featured in the latest issue of the European Medical Writers Association (EMWA) Journal. 🎉 Within, we discuss: 📝 Characteristics and benefits of medical writers with emotional intelligence 📝 Approaches to enhance emotional intelligence skills 📝 Scales to measure emotional intelligence To read the full EMWA issue, click here: https://hubs.li/Q02F_fzk0 Is emotional intelligence important to you? Share your thoughts in the comments and read our article here: https://hubs.li/Q02F_fPl0 Thank you to Dr. Ananya Bhowmick (PhD), Seema Kaveeshwar, and Susmita Sahu for your leadership in writing this! #MedicalWriting #EmotionalIntelligence #OneMMS
-
Great news! MMS recently completed the final phase of our annual ISO audit (ISO 9001:2015 and ISO 27001:2022) and we rose to the occasion with absolutely no observations or findings. Thank you to our #OneMMS team who brings a sense of urgency and leadership (SOUL) every day to ensure that quality is the most critical component in the work that we do! MMS remains as one of the few CROs to be ISO certified since inception, standing as a trusted third-party source to verify our credibility among global Sponsors and business partners. Learn more about working with MMS here: https://hubs.li/Q02Fz4Wv0 #ISO9001 #ISO27001 #DrugDevelopment #OneMMS
-
Happy 4th of July to our US colleagues, clients, and friends from all of us at MMS! As we celebrate Independence Day, we reflect on the values of freedom and innovation, and we celebrate the spirit of collaboration and excellence that defines our team. Together, we continue to push boundaries, drive innovation, and deliver solutions that make a difference. Wishing you all a safe and joyful holiday filled with fun, family, and fireworks! 🌟 #IndependenceDay #OneMMS
-
New article! To help Sponsor teams in the overwhelming task of identifying and justifying what is and is not company confidential information (CCI), MMS transparency experts just released a new blog post titled, “Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules.” Pre- and post-implementation tips, as well as recommendations for a plan and prepare mindset, are detailed within. Read this: https://hubs.li/Q02FcWKy0 #clinicaltrialtransparency #EUCTR #clinicaltrials